Copley
This article was originally published in The Tan Sheet
Executive Summary
Daniel Karpolinski joins as CEO and president of the Canton, Mass.-based generic drug firm. Karpolinski was formerly president and CEO of CoCensys. The Copley position has not been filled since February 1997, when interim President Kenneth Larsen stepped down but remained chairman of the board. Larsen will continue as a board member; Karpolinski will become chairman. The last CEO at Copley was Gabriel Cipau, PhD, who resigned in July 1996...